Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Brookings conference on post-market safety

Executive Summary

Brookings Institution's Engelberg Center for Health Care Reform will hold a conference in Washington, D.C., June 13 on drug safety and post-market evidence, hosted by center Director Mark McClellan. During the conference, FDA Commissioner Andrew von Eschenbach and CDER Director Janet Woodcock are scheduled to discuss the agency's new Sentinel initiative, along with Richard Platt, Harvard University, Marcus Wilson, from WellPoint's HealthCore unit, and Janet Marchibroda, eHealth Initiative. Some details on the Sentinel project were announced by FDA May 22. Other conference participants will include Garry Neil, J&J, and Arnold Chan, i3 Drug Safety

Related Content




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts